Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferrara, J. L.M.
Right arrow Articles by Krenger, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrara, J. L.M.
Right arrow Articles by Krenger, W.
Stem Cells, Vol. 14, No. 5, 473-489, September 1996
© 1996 AlphaMed Press

CONCISE REVIEW

The Immunopathophysiology of Acute Graft-Versus-Host-Disease

James L.M. Ferrara, Kenneth R. Cooke, Luying Pan, Werner Krenger

Division of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA

Key Words. Graft-versus-host-disease • Cytokines • Bone marrow transplantation • Th1/Th2 cells • Review

Correspondence: Dr. Werner Krenger, Division of Pediatric Oncology, D1638, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.

The major complication after allogeneic bone marrow transplantation (BMT) is the development of graft-versus-host-disease (GVHD). This disease is initiated during the conditioning of the recipient, when host tissues are damaged. During the afferent phase of the disease, alloreactive donor T cells recognize foreign major and minor histocompatibility antigens of host tissues. The efferent phase includes activation of inflammatory effector cells as well as the secretion of cytopathic molecules which induce pathology in skin, gastrointestinal tract, liver, lung, and the immune system. Substantial experimental and clinical evidence now indicates a central role of cytokines in the immunopathophysiology of acute GVHD, which forms the basis of this review. The balance between cytokines released by T helper 1 (Th1) cells (interleukin 2, interferon-{gamma}) or by T helper 2 (Th2) cells (interleukin 4, interleukin 10) after allogeneic BMT is hypothesized to govern the extent of the systemic inflammatory response. Because Th2 cytokines can inhibit the production of proinflammatory cytokines such as interleukin 1 and tumor necrosis factor-{alpha}, a Th1->Th2 shift in the initial response of donor T cells may interrupt the cytokine cascade and thus offer a new approach to the prevention and treatment of acute GVHD. Successful interventions to modify the response of donor T cells may obviate the need for T cell depletion and thereby avoid the increased risk of relapse of malignancy and impairment of donor cell engraftment.




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
A. R. Fraser, G. Cook, I. M. Franklin, J. G. Templeton, M. Campbell, T. L. Holyoake, and J. D. M. Campbell
Immature monocytes from G-CSF-mobilized peripheral blood stem cell collections carry surface-bound IL-10 and have the potential to modulate alloreactivity
J. Leukoc. Biol., October 1, 2006; 80(4): 862 - 869.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. M. El-Hayek, T. E. Rogers, and G. R. Brown
The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD
J. Leukoc. Biol., October 1, 2005; 78(4): 1001 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. H. Kaplan, B. E. Anderson, J. M. McNiff, D. Jain, M. J. Shlomchik, and W. D. Shlomchik
Target Antigens Determine Graft-versus-Host Disease Phenotype
J. Immunol., November 1, 2004; 173(9): 5467 - 5475.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. A. Wysocki, S. B. Burkett, A. Panoskaltsis-Mortari, S. L. Kirby, A. D. Luster, K. McKinnon, B. R. Blazar, and J. S. Serody
Differential Roles for CCR5 Expression on Donor T Cells during Graft-versus-Host Disease Based on Pretransplant Conditioning
J. Immunol., July 15, 2004; 173(2): 845 - 854.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Spaner, X. Sheng-Tanner, and A. C. Schuh
Aberrant regulation of superantigen responses during T-cell reconstitution and graft-versus-host disease in immunodeficient mice
Blood, August 28, 2002; 100(6): 2216 - 2224.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
U. F. Hartwig, M. Robbers, C. Wickenhauser, and C. Huber
Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death
Blood, April 15, 2002; 99(8): 3041 - 3049.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Cavet, A. M. Dickinson, J. Norden, P. R. A. Taylor, G. H. Jackson, and P. G. Middleton
Interferon-{gamma} and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation
Blood, September 1, 2001; 98(5): 1594 - 1600.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. d. C. Bittencourt, S. Perruche, E. Contassot, S. Fresnay, M.-H. Baron, R. Angonin, F. Aubin, P. Herve, P. Tiberghien, and P. Saas
Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers
Blood, July 1, 2001; 98(1): 224 - 230.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. S. Serody, S. E. Burkett, A. Panoskaltsis-Mortari, J. Ng-Cashin, E. McMahon, G. K. Matsushima, S. A. Lira, D. N. Cook, and B. R. Blazar
T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease
Blood, November 1, 2000; 96(9): 2973 - 2980.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
J. C Morris and T. A Waldmann
Advances in interleukin 2 receptor targeted treatment
Ann Rheum Dis, November 1, 2000; 59(90001): i109 - 114.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Cavet, P. G. Middleton, M. Segall, H. Noreen, S. M. Davies, and A. M. Dickinson
Recipient Tumor Necrosis Factor-alpha and Interleukin-10 Gene Polymorphisms Associate With Early Mortality and Acute Graft-Versus-Host Disease Severity in HLA-Matched Sibling Bone Marrow Transplants
Blood, December 1, 1999; 94(11): 3941 - 3946.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
D. Spaner, X. Sheng-Tanner, K. Raju, B. Rabinovich, H. Messner, and R. G. Miller
Long-term persistence of IL-2-unresponsive allogeneic T cells in sublethally irradiated SCID mice
Int. Immunol., October 1, 1999; 11(10): 1601 - 1614.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Przepiorka, T. L. Smith, J. Folloder, I. Khouri, N. T. Ueno, R. Mehra, M. Korbling, Y. O. Huh, S. Giralt, J. Gajewski, et al.
Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Blood Stem Cell Transplantation
Blood, August 15, 1999; 94(4): 1465 - 1470.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
D. Zeng, D. Lewis, S. Dejbakhsh-Jones, F. Lan, M. Garcia-Ojeda, R. Sibley, and S. Strober
Bone Marrow NK1.1- and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host Disease
J. Exp. Med., April 5, 1999; 189(7): 1073 - 1081.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. V. Sorg, G. Kogler, and P. Wernet
Identification of Cord Blood Dendritic Cells as an Immature CD11c- Population
Blood, April 1, 1999; 93(7): 2302 - 2307.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Spaner, K. Raju, B. Rabinovich, and R. G. Miller
A Role for Perforin in Activation-Induced T Cell Death In Vivo: Increased Expansion of Allogeneic Perforin-Deficient T Cells in SCID mice
J. Immunol., January 15, 1999; 162(2): 1192 - 1199.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Adler, J. L. Beland, W. Kozlow, N. C. Del-Pan, L. Kobzik, and I. J. Rimm
A Role for Transforming Growth Factor-beta 1 in the Increased Pneumonitis in Murine Allogeneic Bone Marrow Transplant Recipients With Graft-Versus-Host Disease After Pulmonary Herpes Simplex Virus Type 1 Infection
Blood, October 1, 1998; 92(7): 2581 - 2589.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1996 by AlphaMed Press.